Zhong Lei, Zhu Zhong-Zheng, Shen Yanying, Sun Guangyuan, Zhao Xuewei, Zhang Shirong, Yin Xiaolu, Zhu Jianshan, Xu Zhifei, Zhu Guanshan
Department of Thoracic Surgery, Changzheng Hospital, Second Military Medical University, Shanghai, China.
Asian Pac J Cancer Prev. 2011;12(7):1771-6.
The incidence of esophageal squamous cell cancer (ESCC) is strikingly variable by geographic area, which reflect different exposures to risk factors, including genetic predisposition. Previous studies of ESCC patients from several high-risk populations suggested that BRCA2 might play a role in the etiology. This study was conducted to screen for mutations of BRCA2 gene in ESCC cases from a low-risk population.
Forty-seven ESCC patients from a low-risk area of Southeast China were screened for mutations in the entire coding region of the BRCA2 gene by direct sequencing.
No somatic mutations were observed in tumors. In total, 9 germline missense point mutations, each in one patient, were identified in male sporadic patients, with a mutation frequency of 19%. Of the 9 mutations, 7 were of heterozygous, while the remaining 2 were homozygous. Screening of an additional 94 healthy controls for the 9 mutations identified in ESCC cases showed that there was only 2 (2%) positive individuals, each carrying one of the mutations. Thus the mutation frequency in ESCC cases (19%) was significantly higher than that in healthy controls (OR = 10.9, 95% CI = 2.2-52.8, P = 0.003). No significant associations were observed for germline BRCA2 mutations with age, sex, cigarette smoking, alcohol drinking and family history of cancer.
This series of cases from a low-risk Chinese population presented the highest frequency of germline BRCA2 mutations in ESCC reported to date, highlighting possible etiology roles in this population.
食管鳞状细胞癌(ESCC)的发病率在不同地理区域差异显著,这反映了包括遗传易感性在内的不同风险因素暴露情况。此前对来自多个高危人群的ESCC患者的研究表明,BRCA2可能在病因学中起作用。本研究旨在筛查低危人群ESCC病例中BRCA2基因的突变情况。
对来自中国东南部低危地区的47例ESCC患者,通过直接测序法筛查BRCA2基因整个编码区的突变情况。
在肿瘤中未观察到体细胞突变。共在男性散发性患者中鉴定出9个种系错义点突变,每位患者1个,突变频率为19%。在这9个突变中,7个为杂合突变,其余2个为纯合突变。对ESCC病例中鉴定出的9个突变在另外94名健康对照中进行筛查,结果显示只有2名(2%)个体呈阳性,每人携带其中1个突变。因此,ESCC病例中的突变频率(19%)显著高于健康对照(OR = 10.9,95% CI = 2.2 - 52.8,P = 0.003)。未观察到种系BRCA2突变与年龄、性别、吸烟、饮酒及癌症家族史之间存在显著关联。
这一系列来自中国低危人群的病例呈现出了迄今为止报道的ESCC中种系BRCA2突变的最高频率,突出了其在该人群中可能的病因学作用。